nadph and glutathione levels gliomas The role of in brain tumor drug resistance A cell state-specific metabolic vulnerability
Description
I.SunojV
Replacing bleomycin with brentuximab vedotin in the ABVD regimen has demonstrated promising outcomes
R., Freeman, M
10.1016/j.biocel.2015.05.008 5 AlladaR.BassJ
